Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes

PLoS One. 2015 Jul 21;10(7):e0133672. doi: 10.1371/journal.pone.0133672. eCollection 2015.

Abstract

Introduction: Circulating levels of the inflammatory marker YKL-40 are elevated in cardiovascular disease and obesity-related type 2 diabetes (T2D), and serum YKL-40 levels are related to elements of dyslipidaemia.

Objective: We aimed to investigate the associations between serum YKL-40 and obesity-related traits in a Danish sample of non-diabetic relatives to T2D patients and, furthermore, to estimate the heritability of YKL-40.

Research design and methods: 324 non-diabetic individuals with family relation to a T2D patient were included in the study. The participants underwent oral- and intravenous glucose tolerance tests for estimation of glucose tolerance and surrogate measures of insulin sensitivity. Anthropometric measures were retrieved and biochemical measures of the plasma lipid profile and serum YKL-40 levels were obtained. Association-analyses between serum YKL-40 and obesity-related traits and estimates of the narrow sense heritability of YKL-40 were based on a polygenic variance component model.

Results: Fasting serum levels of YKL-40 were positively associated with waist-hip-ratio (p<0.001) and fasting plasma triglyceride levels (p<0.001). None of the insulin sensitivity indexes were significantly associated with YKL-40. According to the AE model, the familiality-estimate h2 of YKL-40 was 0.45 (SE 0.13). When the ACE-model was applied, the heritability-estimate h2 of YKL-40 did not reach statistical significance.

Conclusions: Our results suggest a role of serum YKL-40 in obesity-related low grade inflammation, but do not indicate that YKL-40 is directly involved in the development of T2D.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipokines / blood*
  • Adult
  • Anthropometry
  • Biomarkers / blood
  • Chitinase-3-Like Protein 1
  • Comorbidity
  • Denmark
  • Diabetes Complications / diagnosis
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Dyslipidemias / metabolism*
  • Female
  • Genetic Predisposition to Disease
  • Glucose Tolerance Test
  • Homeostasis
  • Humans
  • Inflammation
  • Insulin Resistance
  • Lectins / blood*
  • Male
  • Middle Aged
  • Obesity / complications
  • Obesity / metabolism*
  • Risk Factors
  • Triglycerides / blood
  • Waist-Hip Ratio

Substances

  • Adipokines
  • Biomarkers
  • CHI3L1 protein, human
  • Chitinase-3-Like Protein 1
  • Lectins
  • Triglycerides

Grants and funding

The study was supported by grants from The Novo Nordisk Foundation, The Research Foundation of Copenhagen University Hospital Herlev, The Jacobsen Foundation and The A.P. Moeller and wife Chastine McKinney Moeller Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.